Angela L. Kleiman - Mar 3, 2025 Form 4 Insider Report for ESSEX PROPERTY TRUST, INC. (ESS)

Signature
/s/ Brennan McGreevy, Attorney in Fact
Stock symbol
ESS
Transactions as of
Mar 3, 2025
Transactions value $
-$534,018
Form type
4
Date filed
3/5/2025, 05:51 PM
Previous filing
Feb 20, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESS Common Stock Options Exercise $1.06M +4.93K +36.08% $214.79 18.6K Mar 3, 2025 Direct F1, F2
transaction ESS Common Stock Sale -$1.55M -4.93K -26.51% $314.99 13.7K Mar 3, 2025 Direct F1, F3
transaction ESS Common Stock Options Exercise $85.9K +400 +2.93% $214.79 14.1K Mar 4, 2025 Direct F1, F2
transaction ESS Common Stock Sale -$126K -400 -2.84% $315.12 13.7K Mar 4, 2025 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ESS Stock Option (Right to Purchase) Options Exercise $0 -4.93K -30.5% $0.00 11.2K Mar 3, 2025 Common Stock 4.93K $214.79 Direct F1, F5
transaction ESS Stock Option (Right to Purchase) Options Exercise $0 -400 -3.56% $0.00 10.8K Mar 4, 2025 Common Stock 400 $214.79 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions report in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Under the terms of the stock options, the maximum value that the reporting person could receive is $100 per share.
F3 Represents the weighted average sale price for the number of shares sold. The actual sales prices range between $314.64 and $315.47. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
F4 Represents the weighted average sale price for the number of shares sold. The actual sales prices range between $314.77 and $315.45. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
F5 1/3 of these stock options vested on December 9, 2023 and 1/3 on each anniversary thereafter ending on December 9, 2025.